ENTITY
pancreatic ductal adenocarcinoma
pancreatic ductal adenocarcinoma
PulseAugur coverage of pancreatic ductal adenocarcinoma — every cluster mentioning pancreatic ductal adenocarcinoma across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
2
2 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Daraxonrasib doubles survival for pancreatic cancer patients
Daraxonrasib, a new drug developed by Revolution Medicines, has shown significant promise in treating pancreatic ductal adenocarcinoma, a notoriously deadly cancer. In a Phase 3 trial, the drug doubled survival duration…
-
AI benchmark tackles pancreatic cancer vascular invasion with uncertainty-aware models
Researchers have introduced the CURVAS-PDACVI Dataset and Challenge, an open benchmark designed to improve AI's ability to assess vascular invasion in pancreatic ductal adenocarcinoma (PDAC). This benchmark addresses th…